166 related articles for article (PubMed ID: 31265056)
21. On the intra-host dynamics of HIV-1 infections.
Stilianakis NI; Schenzle D
Math Biosci; 2006 Jan; 199(1):1-25. PubMed ID: 16343556
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
[TBL] [Abstract][Full Text] [Related]
23. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.
Allers K; Hütter G; Hofmann J; Loddenkemper C; Rieger K; Thiel E; Schneider T
Blood; 2011 Mar; 117(10):2791-9. PubMed ID: 21148083
[TBL] [Abstract][Full Text] [Related]
24. A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells.
Hultquist JF; Schumann K; Woo JM; Manganaro L; McGregor MJ; Doudna J; Simon V; Krogan NJ; Marson A
Cell Rep; 2016 Oct; 17(5):1438-1452. PubMed ID: 27783955
[TBL] [Abstract][Full Text] [Related]
25. Mathematical analysis of the global dynamics of a model for HIV infection of CD4+ T cells.
Wang L; Li MY
Math Biosci; 2006 Mar; 200(1):44-57. PubMed ID: 16466751
[TBL] [Abstract][Full Text] [Related]
26. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
[TBL] [Abstract][Full Text] [Related]
27. Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cure.
Khan A; Paneerselvam N; Lawson BR
Clin Immunol; 2023 Oct; 255():109741. PubMed ID: 37611838
[TBL] [Abstract][Full Text] [Related]
28. Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.
Kaminski R; Chen Y; Fischer T; Tedaldi E; Napoli A; Zhang Y; Karn J; Hu W; Khalili K
Sci Rep; 2016 Mar; 6():22555. PubMed ID: 26939770
[TBL] [Abstract][Full Text] [Related]
29. CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.
Reynes J; Portales P; Segondy M; Baillat V; André P; Avinens O; Picot MC; Clot J; Eliaou JF; Corbeau P
AIDS; 2001 Sep; 15(13):1627-34. PubMed ID: 11546936
[TBL] [Abstract][Full Text] [Related]
30. Infection dynamics in HIV-specific CD4 T cells: does a CD4 T cell boost benefit the host or the virus?
Wodarz D; Hamer DH
Math Biosci; 2007 Sep; 209(1):14-29. PubMed ID: 17379260
[TBL] [Abstract][Full Text] [Related]
31. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
[TBL] [Abstract][Full Text] [Related]
32. The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission.
Guo T; Qiu ZP
Math Biosci Eng; 2019 Jul; 16(6):6822-6841. PubMed ID: 31698590
[TBL] [Abstract][Full Text] [Related]
33. The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV.
Karuppusamy KV; Babu P; Thangavel S
Stem Cell Rev Rep; 2021 Oct; 17(5):1607-1618. PubMed ID: 33788143
[TBL] [Abstract][Full Text] [Related]
34. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
Gene; 2020 May; 741():144568. PubMed ID: 32165289
[TBL] [Abstract][Full Text] [Related]
35. The emerging race to cure HIV infections.
Cohen J
Science; 2011 May; 332(6031):784-5, 787-9. PubMed ID: 21566173
[No Abstract] [Full Text] [Related]
36. Effects of periodic intake of drugs of abuse (morphine) on HIV dynamics: Mathematical model and analysis.
Mutua JM; Wang FB; Vaidya NK
Math Biosci; 2020 Aug; 326():108395. PubMed ID: 32485213
[TBL] [Abstract][Full Text] [Related]
37. Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
Zaunders JJ; Kaufmann GR; Cunningham PH; Smith D; Grey P; Suzuki K; Carr A; Goh LE; Cooper DA
J Infect Dis; 2001 Mar; 183(5):736-43. PubMed ID: 11181150
[TBL] [Abstract][Full Text] [Related]
38. CCR5-edited gene therapies for HIV cure: Closing the door to viral entry.
Haworth KG; Peterson CW; Kiem HP
Cytotherapy; 2017 Nov; 19(11):1325-1338. PubMed ID: 28751153
[TBL] [Abstract][Full Text] [Related]
39. The Fractional Differential Model of HIV-1 Infection of CD4
Lichae BH; Biazar J; Ayati Z
Comput Math Methods Med; 2019; 2019():4059549. PubMed ID: 30728851
[TBL] [Abstract][Full Text] [Related]
40. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
